Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, Kemp A, Erickson BR, Comer JA, Campbell S, Cannon DL, Khristova ML, Atimnedi P, Paddock CD, Kent Crockett RJ, Flietstra TD, Warfield KL, Unfer R, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Rollin PE, Ksiazek TG, Nichol ST, Towner JS, Kawaoka Y. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 2012;8(10):e1002877. [PMC free article: PMC3464226] [PubMed: 23055920]

Amman BR, Jones ME, Sealy TK, Uebelhoer LS, Schuh AJ, Bird BH, Coleman-McCray JD, Martin BE, Nichol ST, Towner JS. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis. 2015;51(1):113–124. [PMC free article: PMC5022530] [PubMed: 25375951]

Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014;371(15):1418–1425. [PubMed: 24738640]

Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, García-Sastre A, Palese P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA. 2000;97(22):12289–12294. [PMC free article: PMC17334] [PubMed: 11027311]

Bausch DG. The year that Ebola virus took over West Africa: Missed opportunities for prevention. Am J Trop Med Hygiene. 2015;92(2):229–232. [PMC free article: PMC4347318] [PubMed: 25561568]

Bausch DG, Schwarz L. Outbreak of Ebola virus disease in Guinea: Where ecology meets economy. PLoS Negl Trop Dis. 2014;8(7):e3056. [PMC free article: PMC4117598] [PubMed: 25079231]

Bornholdt ZA, Noda T, Abelson DM, Halfmann P, Wood MR, Kawaoka Y, Saphire EO. Structural rearrangement of Ebola virus VP40 begets multiple functions in the virus life cycle. Cell. 2013;154(4):763–774. [PMC free article: PMC4138722] [PubMed: 23953110]

Bray M, Mahanty S. Ebola hemorrhagic fever and septic shock. J Infect Dis. 2003;188(11):1613–1617. [PubMed: 14639530]

Canadian Critical Care Society, Canadian Association of Emergency Physicians, and Association of Medical Microbiology & Infectious Diseases Canada. Ebola clinical care guidelines: A guide for clinicians in Canada. Markham, ON: Canadian Critical Care Society; 2014.

CDC (U.S. Centers for Disease Control and Prevention). Filoviridae. 2014. [November 3, 2016]. http://www​.cdc.gov/vhf​/virus-families/filoviridae.html.

CDC. Interim guidance for U.S. Hospital preparedness for patients under investigation (PUIs) or with confirmed Ebola virus disease (EVD): A framework for a tiered approach. 2015. [June 9, 2015]. http://www​.cdc.gov/vhf​/ebola/hcp/us-hospital-preparedness​.html.

Cohen J. Infectious disease. Ebola vaccines racing forward at record pace. Science. 2014;345(6202):1228–1229. [PubMed: 25214582]

Cooper D, Wright KJ, Calderon PC, Guo M, Nasar F, Johnson JE, Coleman JW, Lee M, Kotash C, Yurgelonis I, Natuk RJ, Hendry RM, Udem SA, Clarke DK. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice. J Virol. 2008;82(1):207–219. [PMC free article: PMC2224363] [PubMed: 17942549]

ECDC (European Centre for Disease Prevention and Control). Communicable disease threats report, 25, 14-20 June 2015. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015a.

ECDC. ECDC updated risk assessment: Significant drop of Ebola cases in West Africa but control efforts still needed. 2015b. [November 3, 2016]. http://ecdc​.europa.eu​/en/press/news/_layouts​/forms/News_DispForm​.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=1201.

Edelstein M, Angelides P, Heymann DL. Ebola: The challenging road to recovery. Lancet. 2015;385(9984):2234–2235. [PubMed: 25678357]

Fairley JK, Kozarsky PE, Kraft CS, Guarner J, Steinberg JP, Anderson E, Jacob JT, Meloy P, Gillespie D, Espinoza TR, Isakov A, Vanairsdale S, Baker E, Wu HM. Ebola or not? Evaluating the ill traveler from Ebola-affected countries in West Africa. Open Forum Infect Dis. 2016;3(1):ofw005. [PMC free article: PMC4766384] [PubMed: 26925428]

Fasina FO, Shittu A, Lazarus D, Tomori O, Simonsen L, Viboud C, Chowell G. Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014. Euro Surveill. 2014;19(40):20920. [PubMed: 25323076]

Geisbert TW, Feldmann H. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J Infect Dis. 2011;204(Suppl 3):S1075–S1081. [PMC free article: PMC3218670] [PubMed: 21987744]

Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study. Lancet. 2010;375(9729):1896–1905. [PMC free article: PMC7138079] [PubMed: 20511019]

Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369–1372. [PMC free article: PMC4431643] [PubMed: 25214632]

Gostin LO, Friedman EA. Ebola: A crisis in global health leadership. Lancet. 2014;384(9951):1323–1325. [PubMed: 25306563]

Hashiguchi T, Fusco ML, Bornholdt ZA, Lee JE, Flyak AI, Matsuoka R, Kohda D, Yanagi Y, Hammel M, Crowe JE Jr., Saphire EO. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell. 2015;160(5):904–912. [PMC free article: PMC4344967] [PubMed: 25723165]

Hayman DT. Biannual birth pulses allow filoviruses to persist in bat populations. Proc Biol Sci. 2015;282(1803):20142591. [PMC free article: PMC4345444] [PubMed: 25673678]

Hayman DT, Yu M, Crameri G, Wang LF, Suu-Ire R, Wood JL, Cunningham AA. Ebola virus antibodies in fruit bats, Ghana, West Africa. Emerg Infect Dis. 2012;18(7):1207–1209. [PMC free article: PMC3376795] [PubMed: 22710257]

IOM and NRC (Institute of Medicine and National Research Council). Sustaining global surveillance and response to emerging zoonotic diseases. Washington, DC: The National Academies Press; 2009. [PubMed: 25009943]

Jahrling PB, Geisbert JB, Swearengen JR, Larsen T, Geisbert TW. Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates. J Infect Dis. 2007;196(Suppl 2):S400–S403. [PubMed: 17940976]

Kortepeter MG, Smith PW, Hewlett A, Cieslak TJ. Caring for patients with Ebola: A challenge in any care facility. Ann Intern Med. 2015;162(1):68–69. [PubMed: 25320965]

Kugelman JR, Lee MS, Rossi CA, McCarthy SE, Radoshitzky SR, Dye JM, Hensley LE, Honko A, Kuhn JH, Jahrling PB, Warren TK, Whitehouse CA, Bavari S, Palacios G. Ebola virus genome plasticity as a marker of its passaging history: A comparison of in vitro passaging to non-human primate infection. PLoS ONE. 2012;7(11):e50316. [PMC free article: PMC3509072] [PubMed: 23209706]

Kupferschmidt K. Nigerian virologist delivers scathing analysis of Africa's response to Ebola. Science Magazine. 2014 [November 3, 2016]; http://news​.sciencemag​.org/africa/2014/11​/nigerian-virologist-delivers-scathing-analysis-africas-response-ebola.

Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Delicat A, Paweska JT, Gonzalez JP, Swanepoel R. Fruit bats as reservoirs of Ebola virus. Nature. 2005;438(7068):575–576. [PubMed: 16319873]

Litterman N, Lipinski C, Ekins S. Small molecules with antiviral activity against the Ebola virus. F1000Res. 2015;4(38) [PMC free article: PMC4335594] [PubMed: 25713700]

Maganga GD, Kapetshi J, Berthet N, Kebela Ilunga B, Kabange F, Mbala Kingebeni P, Mondonge V, Muyembe JJ, Bertherat E, Briand S, Cabore J, Epelboin A, Formenty P, Kobinger G, Gonzalez-Angulo L, Labouba I, Manuguerra JC, Okwo-Bele JM, Dye C, Leroy EM. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med. 2014;371(22):2083–2091. [PubMed: 25317743]

Marí Saéz A, Weiss S, Nowak K, Lapeyre V, Zimmermann F, Dux A, Kuhl HS, Kaba M, Regnaut S, Merkel K, Sachse A, Thiesen U, Villanyi L, Boesch C, Dabrowski PW, Radonic A, Nitsche A, Leendertz SA, Petterson S, Becker S, Krahling V, Couacy-Hymann E, Akoua-Koffi C, Weber N, Schaade L, Fahr J, Borchert M, Gogarten JF, Calvignac-Spencer S, Leendertz FH. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med. 2014;7(1):17–23. [PMC free article: PMC4309665] [PubMed: 25550396]

Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML. Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014-2015. MMWR Suppl. 2014;63(3):1–14. [PubMed: 25254986]

Miranda ME, Miranda NL. Reston ebolavirus in humans and animals in the Philippines: A review. J Infect Dis. 2011;204(Suppl 3):S757–S760. [PubMed: 21987747]

Mire CE, Geisbert JB, Agans KN, Satterfield BA, Versteeg KM, Fritz EA, Feldmann H, Hensley LE, Geisbert TW. Durability of a vesicular stomatitis virus-based Marburg virus vaccine in nonhuman primates. PLoS ONE. 2014;9(4):e94355. [PMC free article: PMC3997383] [PubMed: 24759889]

Mohan GS, Li W, Ye L, Compans RW, Yang C. Antigenic subversion: A novel mechanism of host immune evasion by Ebola virus. PLoS Pathog. 2012;8(12):e1003065. [PMC free article: PMC3521666] [PubMed: 23271969]

MSF (Médecins Sans Frontières). Pushed to the limit and beyond: A year into the largest ever Ebola outbreaks. Geneva, Switzerland: MSF; 2015.

Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, Colebunders R, Muyembe-Tamfum JJ. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis. 1999;179(Suppl 1):S18–S23. [PubMed: 9988160]

Muyembe-Tamfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A, Paweska JT. Ebola virus outbreaks in Africa: Past and present. Onderstepoort J Vet Res. 2012;79(2):451. [PubMed: 23327370]

Nature. First response, revisited. Nature. 2014;513(7519):459. [PubMed: 25254437]

Olabode AS, Jiang X, Robertson DL, Lovell SC. Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak. Virology. 2015;482:202–207. [PMC free article: PMC4503884] [PubMed: 25880111]

Onishi N. Empty Ebola clinics in Liberia are seen as misstep in U.S. relief effort. New York Times. 2015 [November 3, 2016]; http://www​.nytimes.com​/2015/04/12/world/africa​/idle-ebola-clinics-in-liberia-are-seenas-misstep-in-us-relief-effort​.html?_r=0.

Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Peters CJ, LeDuc JW, Russell PK, Van Herp M, Kapetshi J, Muyembe JJ, Ilunga BK, Strong JE, Grolla A, Wolz A, Kargbo B, Kargbo DK, Sanders DA, Kobinger GP. Transmission of Ebola viruses: What we know and what we do not know. MBio. 2015;6(2):e00137. [PMC free article: PMC4358015] [PubMed: 25698835]

Paweska JT, Jansen van Vuren P, Masumu J, Leman PA, Grobbelaar AA, Birkhead M, Clift S, Swanepoel R, Kemp A. Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with Vero cells-adapted Hogan strain of Marburg virus. PLoS ONE. 2012;7(9):e45479. [PMC free article: PMC3444458] [PubMed: 23029039]

Presidential Commission for the Study of Bioethical Issues. Ethics and Ebola: Public health planning and response. Washington, DC: U.S. Department of Health and Human Services; 2015.

RKI (Robert Koch Institute). Framework Ebola virus disease: Intervention preparedness in Germany. Berlin, Germany: Robert Koch Institute; 2014.

Saphire EO. An update on the use of antibodies against the filoviruses. Immunotherapy. 2013;5(11):1221–1233. [PMC free article: PMC4465755] [PubMed: 24188676]

Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis. 2014;20(7):1176–1182. [PMC free article: PMC4073864] [PubMed: 24959946]

Smith PW, Anderson AO, Christopher GW, Cieslak TJ, Devreede GJ, Fosdick GA, Greiner CB, Hauser JM, Hinrichs SH, Huebner KD, Iwen PC, Jourdan DR, Kortepeter MG, Landon VP, Lenaghan PA, Leopold RE, Marklund LA, Martin JW, Medcalf SJ, Mussack RJ, Neal RH, Ribner BS, Richmond JY, Rogge C, Daly LA, Roselle GA, Rupp ME, Sambol AR, Schaefer JE, Sibley J, Streifel AJ, Essen SG, Warfield KL. Designing a biocontainment unit to care for patients with serious communicable diseases: A consensus statement. Biosecur Bioterror. 2006;4(4):351–365. [PubMed: 17238819]

Srivastava P. Update: Ebola virus disease epidemic—West Africa, February 2015. Atlanta, GA: U.S. Centers for Disease Control and Prevention; 2015. [PMC free article: PMC5779600] [PubMed: 25719681]

Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, Hensley L, Ammendola V, Abbate A, Grazioli F, Foulds KE, Cheng C, Wang L, Donaldson MM, Colloca S, Folgori A, Roederer M, Nabel GJ, Mascola J, Nicosia A, Cortese R, Koup RA, Sullivan NJ. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nat Med. 2014;20(10):1126–1129. [PubMed: 25194571]

Sullivan NJ, Hensley L, Asiedu C, Geisbert TW, Stanley D, Johnson J, Honko A, Olinger G, Bailey M, Geisbert JB, Reimann KA, Bao S, Rao S, Roederer M, Jahrling PB, Koup RA, Nabel GJ. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nat Med. 2011;17(9):1128–1131. [PubMed: 21857654]

Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, Swanepoel R, Paddock CD, Balinandi S, Khristova ML, Formenty PB, Albarino CG, Miller DM, Reed ZD, Kayiwa JT, Mills JN, Cannon DL, Greer PW, Byaruhanga E, Farnon EC, Atimnedi P, Okware S, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Ksiazek TG, Nichol ST, Rollin PE. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 2009;5(7):e1000536. [PMC free article: PMC2713404] [PubMed: 19649327]

Uyeki TM, Erickson BR, Brown S, McElroy AK, Cannon D, Gibbons A, Sealy T, Kainulainen MH, Schuh AJ, Kraft CS, Mehta AK, Lyon GM 3rd, Varkey JB, Ribner BS, Ellison RT 3rd, Carmody E, Nau GJ, Spiropoulou C, Nichol ST, Stroher U. Ebola virus persistence in semen of male survivors. Clin Infect Dis. 2016;62(12):1552–1555. [PubMed: 27045122]

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis. 2011;204(Suppl 3):S941–S946. [PubMed: 21987773]

von Drehle D, Baker A. The Ebola fighters: The ones who answered the call. Time magazine. 2014 [December 10, 2014]; [PubMed: 25668843]

WHO (World Health Organization). Current context and challenges; stopping the epidemic; and preparedness in non-affected countries and regions. Geneva, Switzerland: World Health Organization; 2015a.

WHO. Ebola situation report—10 June 2015. Geneva, Switzerland: World Health Organization; 2015b.

WHO. Ensuring WHO's capacity to prepare for and respond to future large-scale and sustained outbreaks and emergencies. Geneva, Switzerland: World Health Organization; 2015c.

WHO. One year into the Ebola epidemic: A deadly, tenacious and unforgiving virus. Geneva, Switzerland: World Health Organization; 2015d.

WHO. Sexual transmission of the Ebola virus: Evidence and knowledge gaps. Geneva, Switzerland: World Health Organization; 2015e.

WHO. Ebola data and statistics: Situation summary. Geneva, Switzerland: World Health Organization; 2016a.

WHO. IHR procedures concerning public health emergencies of international concern (PHEIC). 2016b. [August 11, 2016]. http://www​.who.int/ihr​/procedures/pheic/en.

World Bank. The economic impact of the 2014 Ebola epidemic: Short and medium term estimates for West Africa. Washington, DC: The World Bank Group; 2014.

Wu HM, Fairley JK, Steinberg J, Kozarsky P. The potential Ebola-infected patient in the ambulatory care setting: Preparing for the worst without compromising care. Ann Intern Med. 2015;162(1):66–67. [PubMed: 25329137]

Xie FY, Woodle MC, Lu PY. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov Today. 2006;11(1-2):67–73. [PMC free article: PMC7108327] [PubMed: 16478693]